Need for long term safety studies before recommending viral vector vaccines in kids

Vaccines have played a central role in dealing with COVID-19 pandemic. Now regulatory agencies in USA and around the world have begun approving vaccination for kids. Long term safety profile of live attenuated viral vaccines, inactivated viral vaccines and peptide-based vaccines are well studied in children, are safe and can play a central role in controlling the spread of COVID19 in children. But the long-term safety profile of viral vector-based vaccines is not studied. In the present correspondence we highlight the possibility of random insertional mutagenesis and potential side effects, which might be evident after long-term.  Regulators must take into consideration the possibility of insertional mutagenesis and conduct long term studies before approving the viral vector vaccines in children, so that the public have trust in the regulatory agencies and are compliant towards vaccinating their children with safe and effective vaccines.

[1]  K. Stiasny,et al.  Distinguishing features of current COVID-19 vaccines: knowns and unknowns of antigen presentation and modes of action , 2021, NPJ vaccines.

[2]  M. de Angelis,et al.  Overview of the Main Anti-SARS-CoV-2 Vaccines: Mechanism of Action, Efficacy and Safety , 2021, Infection and drug resistance.

[3]  W. Doerfler.  Adenoviral Vector DNA- and SARS-CoV-2 mRNA-Based Covid-19 Vaccines: Possible Integration into the Human Genome - Are Adenoviral Genes Expressed in Vector-based Vaccines? , 2021, Virus Research.

[4]  Esteban Ortiz Prado,et al.  SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates , 2021, NPJ vaccines.

[5]  G. Baffet,et al.  Generation of proliferating human adult hepatocytes using optimized 3D culture conditions , 2021, Scientific reports.

[6]  F. Bushman,et al.  A long-term study of AAV gene therapy in hemophilia A dogs identifies clonal expansions of transduced liver cells , 2020, Nature Biotechnology.

[7]  E. Vermeulen,et al.  Will the World Ever Be the Same After COVID-19? Two Lessons from the First Global Crisis of a Digital Age , 2020, European Business Organization Law Review.

[8]  Knut Stieger,et al.  Optimizing the DNA Donor Template for Homology-Directed Repair of Double-Strand Breaks , 2017, Molecular therapy. Nucleic acids.

[9]  S. Mittal,et al.  Components of Adenovirus Genome Packaging , 2016, Front. Microbiol..

[10]  G. Stephanopoulos,et al.  Improved Gene Targeting through Cell Cycle Synchronization , 2015, PloS one.

[11]  Yaofeng Zhao,et al.  Mechanism of random integration of foreign DNA in transgenic mice , 2013, Transgenic Research.

[12]  Hans A. Kestler,et al.  Chromosomal Integration of Adenoviral Vector DNA In Vivo , 2010, Journal of Virology.

[13]  D. Court,et al.  Recombineering: a homologous recombination-based method of genetic engineering , 2009, Nature Protocols.

[14]  F. Bushman,et al.  Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. , 2008, The Journal of clinical investigation.

[15]  Y. Agca,et al.  Method for detection and identification of multiple chromosomal integration sites in transgenic animals created with lentivirus. , 2006, BioTechniques.

[16]  F. Ohbayashi,et al.  Correction of chromosomal mutation and random integration in embryonic stem cells with helper-dependent adenoviral vectors. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[17]  M. Weitzman,et al.  Gene therapy: twenty-first century medicine. , 2005, Annual review of biochemistry.

[18]  G. Ciliberto,et al.  Detection of integration of plasmid DNA into host genomic DNA following intramuscular injection and electroporation , 2004, Gene Therapy.

[19]  J. Wolff,et al.  The effect of cell division on the cellular dynamics of microinjected DNA and dextran. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[20]  S. Kochanek,et al.  Frequency and Stability of Chromosomal Integration of Adenovirus Vectors , 1999, Journal of Virology.

[21]  A. MacNeil,et al.  Pediatric Infection-Induced SARS-CoV-2 Seroprevalence Estimation Using Commercial Laboratory Specimens: How Representative Is It of the General U.S. Pediatric Population? , 2022, SSRN Electronic Journal.